Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.26M Sell
161,711
-1,289
-0.8% -$9.46K 1.57% 23
2025
Q2
$1.19M Buy
163,000
+45,010
+38% +$286K 1.56% 25
2025
Q1
$825K Hold
117,990
1.24% 28
2024
Q4
$1.01M Buy
117,990
+1,990
+2% +$15.1K 1% 26
2024
Q3
$847K Buy
+116,000
New +$963K 1.07% 27

Other funds holding INTT

AMH Equity's INTT Position: Q3 2025 in Review

AMH Equity reduced its inTEST (INTT) stake by 0.79% in Q3 2025, selling an estimated $9.46K and leaving 161,711 shares worth $1.26M. The position accounts for 1.57% of the portfolio, ranked #23.

AMH Equity first reported a position in INTT in Q3 2024 and has held it in 5 quarters since. 45 funds tracked by Wall St. Rank hold INTT as of Q3 2025.

  • AMH Equity held 161,711 shares of inTEST worth $1.26M as of Q3 2025.
  • AMH Equity sold 1,289 inTEST shares in Q3 2025, an estimated $9.46K.
  • inTEST made up 1.57% of AMH Equity's portfolio in Q3 2025, its #23 holding.
  • AMH Equity first reported a position in inTEST in Q3 2024 and has held it in 5 quarters since.
  • 45 funds tracked by Wall St. Rank held inTEST as of Q3 2025.

Based on AMH Equity's 13F filing for Q3 2025, filed 29 Oct 2025.